• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.

作者信息

Bilezikian J P, Morishima A, Bell J, Grumbach M M

机构信息

Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY 10032, USA.

出版信息

N Engl J Med. 1998 Aug 27;339(9):599-603. doi: 10.1056/NEJM199808273390905.

DOI:10.1056/NEJM199808273390905
PMID:9718379
Abstract
摘要

相似文献

1
Increased bone mass as a result of estrogen therapy in a man with aromatase deficiency.芳香化酶缺乏男性接受雌激素治疗后骨量增加。
N Engl J Med. 1998 Aug 27;339(9):599-603. doi: 10.1056/NEJM199808273390905.
2
Bone has a sexually dimorphic response to aromatase deficiency.骨骼对芳香化酶缺乏具有性别二态性反应。
J Bone Miner Res. 2000 Mar;15(3):507-14. doi: 10.1359/jbmr.2000.15.3.507.
3
Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.低剂量连续联合使用共轭雌激素和醋酸甲羟孕酮对绝经后女性更年期症状、体重、骨密度及代谢的影响
Am J Obstet Gynecol. 2001 Nov;185(5):1180-5. doi: 10.1067/mob.2001.117669.
4
The effects of long-term raloxifene and estradiol treatments on bone in a patient with congenital aromatase deficiency.长期使用雷洛昔芬和雌二醇治疗对一名先天性芳香化酶缺乏症患者骨骼的影响。
Bone. 2009 Nov;45(5):827-32. doi: 10.1016/j.bone.2009.03.672. Epub 2009 Apr 5.
5
Exercise-associated amenorrhea, low bone density, and estrogen replacement therapy.运动性闭经、低骨密度与雌激素替代疗法
Arch Intern Med. 1996 Oct 28;156(19):2193-5.
6
Skeletal effects of long-term estrogen and testosterone replacement treatment in a man with congenital aromatase deficiency: evidences of a priming effect of estrogen for sex steroids action on bone.先天性芳香化酶缺乏男性长期雌激素和睾酮替代治疗的骨骼效应：雌激素对性类固醇骨作用的启动效应证据
Bone. 2007 Jun;40(6):1662-8. doi: 10.1016/j.bone.2007.01.022. Epub 2007 Feb 27.
7
Etidronate and hormone replacement therapy (HRT) for postmenopausal women with osteoporosis despite HRT.依替膦酸二钠与激素替代疗法（HRT）用于尽管接受了HRT但仍患有骨质疏松症的绝经后女性。
Arch Gynecol Obstet. 2003 Jun;268(2):105-6. doi: 10.1007/s00404-002-0340-5. Epub 2002 Aug 17.
8
Bone turnover-sex hormone-parathyroid hormone interrelationships in postmenopausal osteoporosis.绝经后骨质疏松症中骨转换-性激素-甲状旁腺激素的相互关系
Boll Soc Ital Biol Sper. 1973 Jul 30;49(12):732-7.
9
Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.阿仑膦酸钠预防60岁以下绝经后妇女骨质流失。绝经后早期干预队列研究组。
N Engl J Med. 1998 Feb 19;338(8):485-92. doi: 10.1056/NEJM199802193380801.
10
Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis.阿仑膦酸盐治疗高转换型骨质疏松症期间骨转换受抑制。
N Engl J Med. 2006 Nov 9;355(19):2048-50. doi: 10.1056/NEJMc062268.

引用本文的文献

1
Rethinking Osteoporosis Drugs: Can We Simultaneously Address Sarcopenia?重新思考骨质疏松症药物：我们能否同时解决肌肉减少症问题？
Int J Mol Sci. 2025 Jul 18;26(14):6924. doi: 10.3390/ijms26146924.
2
Sex-dependent variation in bone adaptation: from degeneration to regeneration.骨骼适应性的性别差异：从退化到再生
J Orthop Translat. 2025 May 5;52:325-343. doi: 10.1016/j.jot.2025.04.011. eCollection 2025 May.
3
Metabolic benefits afforded by estradiol and testosterone in both sexes: clinical considerations.雌激素和雄激素在两性中带来的代谢益处：临床考虑。
J Clin Invest. 2024 Sep 3;134(17):e180073. doi: 10.1172/JCI180073.
4
Aromatase deficiency in transplanted bone marrow cells improves vertebral trabecular bone quantity, connectivity, and mineralization and decreases cortical porosity in murine bone marrow transplant recipients.移植骨髓细胞中的芳香化酶缺乏可改善小鼠骨髓移植受者的椎骨小梁骨量、连通性和矿化，并降低皮质骨孔隙率。
PLoS One. 2024 Feb 5;19(2):e0296390. doi: 10.1371/journal.pone.0296390. eCollection 2024.
5
Converging evidence from exome sequencing and common variants implicates target genes for osteoporosis.外显子测序和常见变异的汇聚证据提示骨质疏松症的靶基因。
Nat Genet. 2023 Aug;55(8):1277-1287. doi: 10.1038/s41588-023-01444-5. Epub 2023 Aug 9.
6
First Ecuadorian statement consensus for the evaluation and treatment of osteoporosis.厄瓜多尔首份骨质疏松评估和治疗共识声明。
Arch Osteoporos. 2023 Jun 15;18(1):81. doi: 10.1007/s11657-023-01263-5.
7
Endocrinal metabolic regulation on the skeletal system in post-menopausal women.绝经后女性骨骼系统的内分泌代谢调节
Front Physiol. 2022 Nov 11;13:1052429. doi: 10.3389/fphys.2022.1052429. eCollection 2022.
8
Associations between physical physique/fitness in children and bone development during puberty: a 4-year longitudinal study.儿童身体形态/体质与青春期骨骼发育的关系：一项为期 4 年的纵向研究。
Sci Rep. 2022 Aug 4;12(1):13427. doi: 10.1038/s41598-022-17623-z.
9
Insights of the role of estrogen in obesity from two models of ERα deletion.从两个 ERα 缺失模型看雌激素在肥胖中的作用。
J Mol Endocrinol. 2022 Apr 5;68(4):179-194. doi: 10.1530/JME-21-0260.
10
Sex hormones, adiposity, and metabolic traits in men and women: a Mendelian randomisation study.性激素、肥胖和男女的代谢特征：一项孟德尔随机化研究。
Eur J Endocrinol. 2022 Feb 15;186(3):407-416. doi: 10.1530/EJE-21-0703.